Literature DB >> 17048019

[Intraocular pressure measurement during the day and night for glaucoma patients and normal controls using Goldmann and Perkins applanation tonometry].

K Wozniak1, A U Köller, E Spörl, A G Böhm, L E Pillunat.   

Abstract

OBJECTIVE: Our aim was to evaluate intraocular pressure (IOP) levels in primary open angle glaucoma (POAG) patients and healthy controls during both the day and night while measuring in an upright as well as in a supine position.
METHODS: In a prospective clinical trial, 30 glaucoma patients on topical treatment and 50 healthy controls received IOP measurements every 4 h for a 24 h period starting at 8 am. Additionally, blood pressure and heart rate were measured and perfusion pressures were calculated. At 12 am IOP was initially measured in a sitting position and then, after 20 min, in a supine position. At midnight this was carried out conversely. At 4 am IOP was measured in a supine position; all other measurements were performed in a sitting position. Measurements in the sitting position were performed by Goldmann and Perkins tonometry and in a supine position by Perkins tonometry.
RESULTS: IOP was 1 mmHg lower in Perkins tonometry measurements compared to Goldmann tonometry. There was no difference between the two patient groups. In a supine position, IOP measured by Perkins tonometry was higher than in an upright position. At 12 am the difference was 1.8 mmHg+/-2.7 mmHg (p=0.001) in healthy subjects and 1.3+/-2.7 mmHg (p=0.013) in the POAG patients. At 12 pm the increase of IOP in the supine position was even more pronounced with 2.4+/-3.4 mmHg in healthy subjects and 5.6+/-3.2 mmHg in the POAG patients (p=0.001). The blood pressure and the perfusion pressure were lowest during night measurements.
CONCLUSIONS: During diurnal IOP measurements in an upright position there were no statistically significant differences in IOP changes between groups. However, in a supine position IOP was significantly higher than in a sitting position and increased more in the glaucoma patients than in healthy controls. This observation might be due to a faulty regulation of the fluid shift in glaucoma patients and could cause progression of glaucomatous damage.

Entities:  

Mesh:

Year:  2006        PMID: 17048019     DOI: 10.1007/s00347-006-1407-7

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  23 in total

1.  DIURNAL VARIATION OF INTRAOCULAR PRESSURE IN TREATED GLAUCOMA. SIGNIFICANCE IN PATIENTS WITH CHRONIC SIMPLE GLAUCOMA.

Authors:  S M DRANCE
Journal:  Arch Ophthalmol       Date:  1963-09

2.  [Applanation tonometry].

Authors:  H GOLDMANN; T SCHMIDT
Journal:  Ophthalmologica       Date:  1957-10       Impact factor: 3.250

3.  Clinical comparison of the measurement of the IOP with the ocular blood flow tonometer, the Tonopen XL and the Goldmann applanation tonometer.

Authors:  M Bafa; I Lambrinakis; M Dayan; M Birch
Journal:  Acta Ophthalmol Scand       Date:  2001-02

4.  Investigation of parameters influencing intraocular pressure increases during sleep.

Authors:  C Wildsoet; M Eyeson-Annan; B Brown; P G Swann; T Fletcher
Journal:  Ophthalmic Physiol Opt       Date:  1993-10       Impact factor: 3.117

5.  Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma.

Authors:  S Asrani; R Zeimer; J Wilensky; D Gieser; S Vitale; K Lindenmuth
Journal:  J Glaucoma       Date:  2000-04       Impact factor: 2.503

6.  The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.

Authors:  Mae O Gordon; Julia A Beiser; James D Brandt; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J Philip Miller; Richard K Parrish; M Roy Wilson; Michael A Kass
Journal:  Arch Ophthalmol       Date:  2002-06

7.  [Early Manifest Glaucoma Trial update 2004].

Authors:  C Erb
Journal:  Ophthalmologe       Date:  2005-03       Impact factor: 1.059

8.  Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group.

Authors: 
Journal:  Am J Ophthalmol       Date:  1998-10       Impact factor: 5.258

9.  Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.

Authors:  Anders Heijl; M Cristina Leske; Bo Bengtsson; Leslie Hyman; Boel Bengtsson; Mohamed Hussein
Journal:  Arch Ophthalmol       Date:  2002-10

10.  Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes.

Authors:  John H K Liu; Xiaoyan Zhang; Daniel F Kripke; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-04       Impact factor: 4.799

View more
  5 in total

1.  Ocular changes over 60 min in supine and prone postures.

Authors:  Allison P Anderson; Gautam Babu; Jacob G Swan; Scott D Phillips; Darin A Knaus; Christine M Toutain-Kidd; Michael E Zegans; Abigail M Fellows; Jiang Gui; Jay C Buckey
Journal:  J Appl Physiol (1985)       Date:  2017-05-25

2.  [Mobile intraocular pressure measurement. From palpation to initial clinical experience with the handheld dynamic contour tonometer].

Authors:  U Schmid; C Kniestedt
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

3.  Relationship of central corneal thickness to postural IOP changes in patients with and without glaucoma in southern India.

Authors:  Stephen J Moster; Ghasem Fakhraie; Rengaraj Venketesh; Mark L Moster; Yuanjun Zhao; Marlene R Moster
Journal:  Int Ophthalmol       Date:  2012-05-11       Impact factor: 2.031

4.  Detecting IOP Fluctuations in Glaucoma Patients.

Authors:  Brenda Nuyen; Kaweh Mansouri
Journal:  Open Ophthalmol J       Date:  2016-02-29

5.  Individualized Significance of 24-Hour Intraocular Pressure Curves for Therapeutic Decisions in Primary Chronic Open-Angle Glaucoma Patients.

Authors:  Mael Lever; Jan Darius Unterlauft; Christian Halfwassen; Nikolaos E Bechrakis; Anke Manthey; Michael R R Böhm
Journal:  Clin Ophthalmol       Date:  2020-05-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.